Style de citation APA (7e éd.)

K, K., N, O., M, F., & M, F. (2019). Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion. Dove Medical Press.

Style de citation Chicago (17e éd.)

K, Kumagai, Ogino N, Fukami M, et Furukawa M. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.

Style de citation MLA (8e éd.)

K, Kumagai, et al. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.